Nomura Holdings’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-23,800
Closed -$3.47M 1681
2023
Q2
$3.47M Buy
+23,800
New +$3.23M 0.01% 585
2022
Q1
Sell
-141,522
Closed -$17.5M 2480
2021
Q4
$17.5M Buy
141,522
+22,557
+19% +$2.95M 0.04% 309
2021
Q3
$17.3M Buy
118,965
+10,197
+9% +$1.5M 0.04% 254
2021
Q2
$17M Buy
+108,768
New +$17.6M 0.04% 239
2021
Q1
Sell
-43,775
Closed -$6.54M 2335
2020
Q4
$6.54M Buy
43,775
+39,140
+844% +$5.53M 0.01% 514
2020
Q3
$612K Buy
+4,635
New +$605K ﹤0.01% 940

Other funds holding ZBH

Nomura Holdings's ZBH Position: Q1 2026 in Review

Nomura Holdings sold out of Zimmer Biomet (ZBH) in Q1 2026, closing a stake of 2,310 shares — an estimated $208K sold.

Nomura Holdings first reported a position in ZBH in Q2 2013 and held it in 37 quarters. The position peaked at $23.8M in Q4 2014. 914 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

  • Nomura Holdings reported no remaining Zimmer Biomet position as of Q1 2026 after selling out during the quarter.
  • Nomura Holdings sold 2,310 Zimmer Biomet shares in Q1 2026, an estimated $208K.
  • Nomura Holdings first reported a position in Zimmer Biomet in Q2 2013 and held it in 37 quarters.
  • Nomura Holdings's Zimmer Biomet position peaked at $23.8M in Q4 2014.
  • 914 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Nomura Holdings's 13F filing for Q1 2026, filed 15 May 2026.